Literature DB >> 9379438

Discovery of a novel class of substituted pyrrolooctahydroisoquinolines as potent and selective delta opioid agonists, based on an extension of the message-address concept.

G Dondio1, S Ronzoni, D S Eggleston, M Artico, P Petrillo, G Petrone, L Visentin, C Farina, V Vecchietti, G D Clarke.   

Abstract

This paper describes the design and synthesis of compounds belonging to a novel class of substituted pyrrolooctahydroisoquinolines which are potent and selective delta opioid agonists. Molecular modeling studies performed on known, selective delta ligands such as (+)-3 and the potent delta agonists SNC 80 led to the identification of the carboxamido moiety of the latter as a putative nonaromatic delta address. Insertion of this moiety onto the octahydroisoquinoline opioid message resulted in (+/-)-5b, a potent and selective delta ligand. The active enantiomer, (-)-5b, displayed nanomolar affinity for the delta receptor (Ki = 0.9 nM) with good mu/delta and kappa/delta binding selectivity ratios (140 and 1480, respectively). In addition, (-)-5b behaved as a full delta agonist in the mouse vas deferens bioassay having an IC50 = 25 nM and being antagonised in the presence of 30 nM naltrindole (NTI). These studies, based on the message-address concept, indicated that the nonaromatic (N,N-diethylamino)carbonyl moiety is a viable alternative to the classical benzene ring as a delta opioid address. Preliminary in vivo studies showed that (+/-)-5b produced a dose-related antinociception in the mouse abdominal constriction test after intracerebroventricular administration (ED50 = 1.6 micrograms/mouse).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379438     DOI: 10.1021/jm9608218

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

Review 1.  Molecular recognition of opioid receptor ligands.

Authors:  Brian E Kane; Bengt Svensson; David M Ferguson
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

2.  Docking studies suggest ligand-specific delta-opioid receptor conformations.

Authors:  Vuk Micovic; Milovan D Ivanovic; Ljiljana Dosen-Micovic
Journal:  J Mol Model       Date:  2008-12-04       Impact factor: 1.810

Review 3.  Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.

Authors:  Sang-Min Lee; Jason M Booe; Augen A Pioszak
Journal:  Eur J Pharmacol       Date:  2015-05-14       Impact factor: 4.432

4.  Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents.

Authors:  H Beaudry; A Proteau-Gagné; Shuang Li; Y Dory; C Chavkin; L Gendron
Journal:  Neuroscience       Date:  2009-03-27       Impact factor: 3.590

5.  Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5.

Authors:  H Beaudry; A-A Mercier-Blais; C Delaygue; C Lavoie; J-L Parent; W Neugebauer; L Gendron
Journal:  Br J Pharmacol       Date:  2015-03-24       Impact factor: 8.739

6.  Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.

Authors:  A M W Taylor; K W Roberts; A A Pradhan; H A Akbari; W Walwyn; K Lutfy; F I Carroll; C M Cahill; C J Evans
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.